Reduced circulating mature-BDNF levels and a diminished mature-BDNF/pro-BDNF ratio in individuals with depression and bipolar disorder prove to be more responsive biomarkers than a reduction in total BDNF levels. Here, BDNF is linked to depressive symptom measurement.